Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation process of brivudine

A technology of bromofuridine and deoxyuracil, applied in the field of medicine, can solve problems such as isomerization of glycoside and bromopyrimidine, and achieve the effects of high reaction yield, reduction of production cost, and improvement of total yield

Active Publication Date: 2010-05-19
SHANGHAI JIAOTONG UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In short, there are three difficulties in the industrial production of bromofuridine: one is the cis-trans isomerization problem when synthesizing (E)-5-(2-bromovinyl)uracil; The third is the purification of intermediates and final products

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation process of brivudine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] (1) Preparation of 5-hydroxymethyl-2'-deoxyuracil (I)

[0029] 2'-deoxyuracil (5.25g, 23.1mmol) and paraformaldehyde (3.11g, 103.5mmol) were dissolved in 0.5M triethylamine aqueous solution (80ml), heated up to 60°C, reacted for four days, and added Paraformaldehyde (4.49g, 149.5mmol; 3.21g, 105.8mmol) was added once, triethylamine (1ml) and water (10ml) were added once in the middle, and finally concentrated and recrystallized in methanol to obtain 4.11g of white solid, namely: 5-Hydroxymethyl-2'-deoxyuracil (I), yield 70%.

[0030] Its characteristic parameters are: 1 H NMR (400MHz, DMSO-d6) δ: 11.34(s, 1H, N-H), 7.71(s, 1H, 6-H), 6.17(t, J=6.8Hz, 1H, 1'-H), 5.26( s, 1H, 3'-OH), 4.97 (s, 2H, 5'-OH and CH 2 O-H), 4.20(q, J=3.2Hz, 1H, 4'-H), 4.10(s, 2H, 5-H), 3.75(q, J=3.2Hz, 1H, 3'-H), 3.57- 3.47(m, 2H, 5'-H), 2.09-1.99(m, 2H, 2'-H)).

[0031] (2) Preparation of 5-formyl-2'-deoxyuracil (II) from compound (I)

[0032] (1) (0.70g, 2.7mmol) and newly prepared mangan...

Embodiment 2

[0041] (1) Preparation of 5-hydroxymethyl-2'-deoxyuracil (I)

[0042] 2'-Deoxyuracil (15.25g, 69.3mmol) and paraformaldehyde (9.96g, 311.9mmol) were dissolved in 0.5M triethylamine aqueous solution (240ml), heated to 60°C, reacted for four days, then every other day Add paraformaldehyde (14.38g, 450.5mmol; 10.18g, 318.8mmol) once, add triethylamine (3ml) and water (30ml) once in the middle, and finally concentrate and recrystallize with methanol to obtain 10.01g of 5-hydroxymethyl Base-2'-deoxyuracil (I), the yield was 56%.

[0043] (2) Preparation of 5-formyl-2'-deoxyuracil (II) from compound (I)

[0044] (I) (1.01g, 3.9mmol) and manganese dioxide (7.78g, 89.5mmol) in 20ml DMF (N, N-dimethylformamide), after reacting at 10 ℃ for 4 days, filter with diatomaceous earth , the resulting filtrate was concentrated and recrystallized in methanol to obtain 0.60 g of 5-formyl-2'-deoxyuracil (II), with a yield of 61%.

[0045] (3) Preparation of (E)-5-(2-carboxyvinyl)-2'-deoxyuracil...

Embodiment 3

[0050] (1) Preparation of 5-hydroxymethyl-2'-deoxyuracil (I)

[0051] The synthesis method refers to (1) in Example 1.

[0052] (2) Preparation of 5-formyl-2'-deoxyuracil (II) from compound (I)

[0053] (I) (0.20g, 0.8mmol) and manganese dioxide (1.54g, 8mmol) (10eq.) in 5ml DMF (N,N-dimethylformamide), after reacting at 10°C for 9 hours, use silicon Manganese dioxide was removed by algal earth suction filtration, concentrated, and passed through a column with ethyl acetate to obtain 0.08 g of 5-formyl-2'-deoxyuracil (II), with a yield of 42%.

[0054] (3) Preparation of (E)-5-(2-carboxyvinyl)-2'-deoxyuracil (III) from compound (II)

[0055] The synthesis method refers to (3) in Example 1.

[0056] (4) Preparation of (E)-5-(2-bromovinyl)-2'-deoxyuracil (IV) from compound

[0057] The synthesis method refers to (4) in Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to medicine technology, and is especially preparation process of brivudine. The preparation process includes the following steps: reaction between the 2'-deoxy uracil material and paraformaldehyde to obtain 5-methylol-2'-deoxy uracil; oxidizing 5-methylol-2'-deoxy uracil with manganese dioxide to prepare 5-formyl-2'-deoxy uracil; condensation of 5-formyl-2'-deoxy uracil and malonic acid to prepare (E)-5-(2-carboxyl vinyl)-2'-deoxy uracil; and reaction of (E)-5-(2-carboxyl vinyl)-2'-deoxy uracil and N-bromo succimide under the action of potassium acetate to obtainthe ultimate product. The present invention has greatly lowered cost, simple operation, high yield, environment friendship and easy use in industrial production.

Description

technical field [0001] The invention relates to a preparation method in the technical field of medicine, in particular to a preparation method of bromfuridine. technical background [0002] Bromofuridine: (E)-5-(2-bromovinyl)-2'-deoxyuracil, referred to as BVDU, is a pyrimidine nucleoside derivative. The compound is currently the most active anti-varicella-herpes virus (VZV) drug, and its potency is 1000 times that of acyclovir. Bromfuridine is mainly used for congenital immunodeficiency caused by herpes zoster, varicella virus skin disease and type I simple virus; or immunosuppression in patients with secondary immunodeficiency (such as after organ transplantation); or cytostatic Skin and mucous membrane infections that occur during drug therapy. It has been confirmed that oral administration of BVDU (125mg / time, 3 times / day, for 5 consecutive days) is effective in treating severe herpes zoster in cancer patients. As a replacement product of antiviral drugs, bromfuridine...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07H19/073
Inventor 张万斌谢芳王春娟
Owner SHANGHAI JIAOTONG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com